Clinical Trial

Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is to learn about the safety and effects of G207 combined with radiation therapy in patients with recurrent or progressive high-grade glioma (HGG).
Trial Details
NCT Number NCT07649070
Lead Sponsor M.D. Anderson Cancer Center
Conditions High Grade Gliomas
Enrollment 38 participants
Start Date 2026-11-30
Primary Completion 2030-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-29